BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 6204790)

  • 1. Serum-responsive expression of carbonyl-metabolizing enzymes in normal and transformed human buccal keratinocytes.
    Staab CA; Ceder R; Roberg K; Grafström RC; Höög JO
    Cell Mol Life Sci; 2008 Nov; 65(22):3653-63. PubMed ID: 18854940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.
    Mantel A; Carpenter-Mendini A; VanBuskirk J; Pentland AP
    Exp Dermatol; 2014 Aug; 23(8):573-8. PubMed ID: 24917395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical models of hierarchically structured cell populations under equilibrium with application to the epidermis.
    Savill NJ
    Cell Prolif; 2003 Feb; 36(1):1-26. PubMed ID: 12558657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C.
    Dlugosz AA; Yuspa SH
    J Cell Biol; 1993 Jan; 120(1):217-25. PubMed ID: 7678013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistep process of squamous differentiation in tracheobronchial epithelial cells in vitro: analogy with epidermal differentiation.
    Jetten AM
    Environ Health Perspect; 1989 Mar; 80():149-60. PubMed ID: 2647475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant progression of an SV40-transformed human epidermal keratinocyte cell line.
    Brown KW; Gallimore PH
    Br J Cancer; 1987 Nov; 56(5):545-54. PubMed ID: 2447927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of UV, 4-NQO and TPA on gene expression in cultured human epidermal keratinocytes.
    Kartasova T; Cornelissen BJ; Belt P; van de Putte P
    Nucleic Acids Res; 1987 Aug; 15(15):5945-62. PubMed ID: 2442723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc and c-fos expression in differentiating mouse primary keratinocytes.
    Dotto GP; Gilman MZ; Maruyama M; Weinberg RA
    EMBO J; 1986 Nov; 5(11):2853-7. PubMed ID: 2431900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumour promotion by phorbol esters and by deep skin wounding.
    Parkinson EK
    Br J Cancer; 1985 Oct; 52(4):479-93. PubMed ID: 2415144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible inhibition of cell differentiation by phorbol esters as a possible mechanism of the promotion step in chemical carcinogenesis.
    Yamasaki H
    IARC Sci Publ; 1980; (27):91-111. PubMed ID: 7002785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of complete and second-stage tumour promoters in normal but not transformed human and mouse keratinocytes.
    Parkinson EK; Pera MF; Emmerson A; Gorman PA
    Carcinogenesis; 1984 Aug; 5(8):1071-7. PubMed ID: 6204790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of human cervical keratinocytes in vitro to tumour promoters and diethylstilboestrol.
    Stanley MA; Crowcroft NS; Quigley JP; Parkinson EK
    Carcinogenesis; 1985 Jul; 6(7):1011-5. PubMed ID: 2410159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subpopulation of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phorbol, 12-myristate, 13-acetate: evidence for an increase in the resistant population following transformation.
    Parkinson EK; Grabham P; Emmerson A
    Carcinogenesis; 1983; 4(7):857-61. PubMed ID: 6191883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of tumour promoters on the multiplication and morphology of cultured human epidermal keratinocytes.
    Parkinson EK; Emmerson A
    Carcinogenesis; 1982; 3(5):525-31. PubMed ID: 6178528
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.